title: Treatment of RAEB-t with intensive chemotherapy and GM-CSF.
abstract: A 55-yr old woman with refractory anaemia with excess of blasts in transformation developed prolonged bone marrow hypoplasia following two courses of mitozantrone and cytosine arabinoside. The administration of granulocyte-monocyte colony stimulating factor after two months of pancytopenia led to recovery of normal bone-marrow function, without any morphological evidence of myelodysplasia, which has persisted until the last blood count (6 months +).
authors.affiliation: Department of Haematology, Lewisham Hospital, London, U.K.
authors.forename: F
authors.initials: F
authors.lastname: Brito-Babapulle
authors.forename: J A
authors.initials: JA
authors.lastname: Lord
authors.forename: D N
authors.initials: DN
authors.lastname: Whitmore
mesh_terms: D000754:Anemia, Refractory, with Excess of Blasts / Q000097:blood / Q000188:drug therapy* / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000187:drug effects* / Q000473:pathology; D003115:Colony-Stimulating Factors / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000008:administration & dosage*; D006801:Humans; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage
chemical_list: D003115:Colony-Stimulating Factors; D006133:Growth Substances; D003561:Cytarabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D008942:Mitoxantrone